MedPath
HSA Approval

SUPIROCIN OINTMENT 2% w/w

SIN11895P

SUPIROCIN OINTMENT 2% w/w

SUPIROCIN OINTMENT 2% w/w

April 24, 2002

UNI DRUG HOUSE

UNI DRUG HOUSE

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantUNI DRUG HOUSE
Licence HolderUNI DRUG HOUSE

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

OINTMENT

TOPICAL

Medical Information

D06AX09

mupirocin

Manufacturer Information

UNI DRUG HOUSE SDN. BHD.

GLENMARK PHARMACEUTICALS LTD

Active Ingredients

MUPIROCIN

2% w/w

Mupirocin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SUPIROCIN OINTMENT 2% w/w - HSA Approval | MedPath